Ludovit Paulis
Overview
Explore the profile of Ludovit Paulis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
1021
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Simko F, Stanko P, Repova K, Baka T, Krajcirovicova K, Aziriova S, et al.
Biomed Pharmacother
. 2024 Mar;
173:116391.
PMID: 38461685
This study investigated whether sacubitril/valsartan or valsartan are able to prevent left ventricular (LV) fibrotic remodelling and dysfunction in two experimental models of pre-hypertension induced by continuous light (24 hours/day)...
2.
Jasenovec T, Radosinska D, Kollarova M, Vrbjar N, Balis P, Trubacova S, et al.
Pharmaceuticals (Basel)
. 2022 Oct;
15(10).
PMID: 36297339
The objective of our study was to contribute to the characterization of monocrotaline-induced pulmonary arterial hypertension (PAH) in a rat model, with emphasis on the renin-angiotensin-aldosterone system, parameters of oxidative...
3.
Simko F, Baka T, Stanko P, Repova K, Krajcirovicova K, Aziriova S, et al.
Biomedicines
. 2022 Aug;
10(8).
PMID: 36009391
This study investigated whether sacubitril/valsartan and ivabradine are able to prevent left ventricular (LV) fibrotic remodelling and dysfunction in a rat experimental model of spontaneous hypertension (spontaneously hypertensive rats, SHRs)...
4.
Rajtik T, Galis P, Bartosova L, Paulis L, Goncalvesova E, Klimas J
Int J Mol Sci
. 2021 Dec;
22(23).
PMID: 34884604
Alternative branches of the classical renin-angiotensin-aldosterone system (RAS) represent an important cascade in which angiotensin 2 (AngII) undergoes cleavage via the action of the angiotensin-converting enzyme 2 (ACE2) with subsequent...
5.
Simko F, Hrenak J, Adamcova M, Paulis L
Int J Mol Sci
. 2021 Apr;
22(6).
PMID: 33809971
The renin-angiotensin-aldosterone system (RAAS) ranks among the most challenging puzzles in cardiovascular medicine [...].
6.
Simko F, Baka T, Repova K, Aziriova S, Krajcirovicova K, Paulis L, et al.
Fundam Clin Pharmacol
. 2020 Oct;
35(4):744-748.
PMID: 33098700
This study investigated whether ivabradine, a selective I current inhibitor reducing heart rate (HR), is able to improve survival and prevent left ventricular (LV) remodeling in isoproterenol-induced heart damage. Wistar...
7.
Stanko P, Baka T, Repova K, Aziriova S, Krajcirovicova K, Barta A, et al.
Front Med (Lausanne)
. 2020 Aug;
7:325.
PMID: 32754607
Hypertension-induced renal injury is characterized by structural kidney alterations and function deterioration. Therapeutics for kidney protection are limited, thus novel renoprotectives in hypertension are being continuously sought out. Ivabradine, an...
8.
Kmecova Z, Veteskova J, Lelkova-Zirova K, Pivackova L, Doka G, Malikova E, et al.
J Cell Mol Med
. 2020 May;
24(12):6943-6951.
PMID: 32395887
Right ventricular (RV) failure is the primary cause of death in pulmonary arterial hypertension (PAH). We hypothesized that heart-relevant microRNAs, that is myomiRs (miR-1, miR-133a, miR-208, miR-499) and miR-214, can...
9.
Szeiffova Bacova B, Radosinska J, Wallukat G, Barancik M, Wallukat A, Knezl V, et al.
Int J Mol Sci
. 2020 Jan;
21(2).
PMID: 31947691
The arrhythmogenic potential of β1-adrenoceptor autoantibodies (β1-AA), as well as antiarrhythmic properties of omega-3 in heart diseases, have been reported while underlying mechanisms are poorly understood. We aimed to test...
10.
Simko F, Reiter R, Paulis L
Hypertens Res
. 2019 Sep;
42(11):1828-1831.
PMID: 31515506
No abstract available.